Showing results (141-150 of 471) with videos related to
Sort By:
Pageof 48
Frontiers in Nutrition|March 1, 2024
Association of tryptophan pathway metabolites with mortality and effectiveness of nutritional support among patients at nutritional risk: secondary analysis of a randomized clinical trialJacqueline Ritz, Carla Wunderle, Franziska Stumpf, et al.BMC Medicine|February 25, 2017
Food for thought: why does the medical community struggle with research about nutritional therapy in the acute care setting?Philipp SchuetzSwiss Medical Weekly|April 24, 2015
"Eat your lunch!" - controversies in the nutrition of the acutely, non-critically ill medical inpatientPhilipp SchuetzClinical Chemistry and Laboratory Medicine|November 1, 2022
How to best use procalcitonin to diagnose infections and manage antibiotic treatmentPhilipp SchuetzClinical Chemistry and Laboratory Medicine|May 26, 2019
A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infectionOlivia L Neeser, Tanja Vukajlovic, Laetitia Felder, et al.BMC Anesthesiology|November 25, 2014
Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patientsAlexander Kutz, Eva Grolimund, Mirjam Christ-Crain, et al.Clinical Chemistry and Laboratory Medicine|February 8, 2021
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational studyClaudia Gregoriano, Daniel Koch, Alexander Kutz, et al.Scientific Reports|April 13, 2021
Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndromeFahim Ebrahimi, Sandrine Andrea Urwyler, Matthias Johannes Betz, et al.Clinical Endocrinology|May 31, 2017
Characteristics and outcomes of patients with profound hyponatraemia due to primary polydipsiaClara O Sailer, Bettina Winzeler, Nicole Nigro, et al.The European Respiratory Journal|July 30, 2016
Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumoniaSebastian A Wirz, Claudine A Blum, Philipp Schuetz, et al.Pageof 48